Peptide Decoding

Tesamorelin + Ipamorelin blend 13 mg vial price

Tesamorelin + Ipamorelin blend 13 mg vials are listed by 6 vendors. Prices run from $88.00 to $127.00, with a median of $100.00, across the 5 showing an exact in-stock price. Last read Sep 29, 2026.

Compare prices
Read the regulatory status before you compare prices.

Tesamorelin on its own is FDA-approved as EGRIFTA, EGRIFTA SV and EGRIFTA WR, for HIV-associated lipodystrophy. Ipamorelin is not approved for anything, and was moved to FDA compounding Category 2. The blend has never been tested in a human trial. An approval that one ingredient holds does not carry over to a combination it was never studied in.

What a 13 mg vial costs

Every vendor we track that lists this exact size, cheapest first. Sort order is price only; affiliate status never changes it.

Median $100.00 a vial, or $7.69 per mg, across the 5 vendors with an exact, in-stock price.

Testing checks: outside lab · HPLC purity · mass spec identity · batch COA · lab named

Sort by
All sizes3 mg5 mg8 mg10 mg12 mg13 mg

    Blends containing this compound

    Cheapest first, laid out like the table above. Every listing is a blend that contains Tesamorelin + Ipamorelin blend, so prices are not comparable with the single-compound table above; per mg uses the total peptide in the vial.

    We earn from these links. It never changes a price or a position here.

    • PeakForm Peptides: "From" price, left out of the range
    Tesamorelin + Ipamorelin blend compound pageCalculatorDosage chart